Using zebrafish to fill the gap between in vitro and rodent models for nicotinic drug development
Publication
, Journal Article
Levin, ED
Published in: Biochemical Pharmacology
October 2011
Duke Scholars
Published In
Biochemical Pharmacology
DOI
ISSN
0006-2952
Publication Date
October 2011
Volume
82
Issue
8
Start / End Page
1038 / 1039
Publisher
Elsevier BV
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 3101 Biochemistry and cell biology
- 1115 Pharmacology and Pharmaceutical Sciences
- 0601 Biochemistry and Cell Biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Levin, E. D. (2011). Using zebrafish to fill the gap between in vitro and rodent models for nicotinic drug development. Biochemical Pharmacology, 82(8), 1038–1039. https://doi.org/10.1016/j.bcp.2011.07.040
Levin, Edward D. “Using zebrafish to fill the gap between in vitro and rodent models for nicotinic drug development.” Biochemical Pharmacology 82, no. 8 (October 2011): 1038–39. https://doi.org/10.1016/j.bcp.2011.07.040.
Levin ED. Using zebrafish to fill the gap between in vitro and rodent models for nicotinic drug development. Biochemical Pharmacology. 2011 Oct;82(8):1038–9.
Levin, Edward D. “Using zebrafish to fill the gap between in vitro and rodent models for nicotinic drug development.” Biochemical Pharmacology, vol. 82, no. 8, Elsevier BV, Oct. 2011, pp. 1038–39. Crossref, doi:10.1016/j.bcp.2011.07.040.
Levin ED. Using zebrafish to fill the gap between in vitro and rodent models for nicotinic drug development. Biochemical Pharmacology. Elsevier BV; 2011 Oct;82(8):1038–1039.
Published In
Biochemical Pharmacology
DOI
ISSN
0006-2952
Publication Date
October 2011
Volume
82
Issue
8
Start / End Page
1038 / 1039
Publisher
Elsevier BV
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 3101 Biochemistry and cell biology
- 1115 Pharmacology and Pharmaceutical Sciences
- 0601 Biochemistry and Cell Biology